Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Carbonyl Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111548341B offers a novel route for lenalidomide key intermediate. Enhanced yield and scalability for pharmaceutical supply chains.
Novel preparation method using NaBH4/CeCl3 achieves over 90% yield for high-purity fragrance and pharmaceutical intermediates, offering significant cost and time advantages over traditional epoxidation routes.